Cryopreservation Equipment Market Size, Share & Forecast Analysis to 2030

The global cryopreservation equipment market valued at around USD 2.5 billion in 2025 and projected to grow at a significant CAGR of around 11% during the forecast period from 2026 to 2030. The market is experiencing steady growth, driven by increasing demand for long-term preservation of biological samples in biobanks, fertility clinics, and cell & gene therapy research. Technological advancements in ultra-low temperature freezers, automated storage systems, and sample monitoring solutions are further enhancing operational efficiency and sample integrity. North America remains the leading regional market, supported by well-established healthcare infrastructure and extensive research activities.

Market Snapshot:

Key Insights:

• Freezers hold the largest product share due to their critical role in long-term storage of biological samples at ultra-low temperatures.
• Liquid Nitrogen remains the dominant cryogen, owing to its cost-effectiveness, superior cooling performance, and widespread use in cryopreservation applications.
• Cell & Gene Therapy is a key application segment, driven by the increasing commercialization of advanced therapies and regenerative medicine.
• North America dominates the global market, supported by advanced healthcare infrastructure, extensive biobanking activities, and strong biotechnology research.

Key Factors Driving the Cryopreservation Equipment Market Growth

The increasing adoption of cell and gene therapies, regenerative medicine, and precision medicine is a major factor driving the growth of the cryopreservation equipment market. Cryopreservation equipment is essential for preserving stem cells, immune cells, embryos, reproductive tissues, and other biological specimens used in research and clinical applications. The rapid expansion of biobanks, fertility clinics, and biopharmaceutical manufacturing facilities, coupled with rising investments in advanced therapies, has significantly increased demand for ultra-low temperature freezers, cryogenic storage systems, and sample preparation equipment. Additionally, stringent quality and traceability requirements for biological sample storage are encouraging healthcare and research organizations to modernize their cryopreservation infrastructure.

Another significant growth driver is the increasing investment in advanced cold-chain and cryogenic infrastructure to support clinical trials and commercial-scale cell and gene therapies. As a recent industry development, Thermo Fisher Scientific announced the opening of a new GMP-certified ultra-cold facility in Bleiswijk, Netherlands, providing ambient-to-cryogenic storage, biorepository storage, packaging, and distribution services for advanced therapies, including cell and gene therapies. This expansion highlights the growing industry focus on strengthening cryogenic storage capacity to ensure the safe handling and preservation of high-value biological materials.

Key Growth Drivers:

• Growing cell and gene therapy research is increasing demand for advanced cryopreservation equipment to preserve biological samples safely and efficiently.
• Expanding biobanks, fertility clinics, and pharmaceutical research are driving investments in reliable cryogenic storage and sample preparation systems globally.
• Advancements in automated cryogenic storage technologies are improving sample integrity, regulatory compliance, and operational efficiency across healthcare and research facilities.

Cryopreservation Equipment Market Restraints

One of the primary restraints affecting the cryopreservation equipment market is the high capital investment and operating costs associated with cryogenic storage systems. Ultra-low temperature freezers, controlled-rate freezing equipment, liquid nitrogen storage systems, and automated monitoring solutions require substantial upfront expenditure, making adoption challenging for small research laboratories, hospitals, and biotechnology startups. In addition, recurring expenses related to maintenance, calibration, energy consumption, and cryogen replenishment increase the total cost of ownership, limiting widespread deployment in cost-sensitive markets.

Another significant challenge is the risk of sample loss due to equipment failure and stringent regulatory compliance requirements. Maintaining consistent ultra-low temperatures and uninterrupted power supply is essential for preserving biological samples, and any system malfunction or temperature fluctuation can compromise valuable specimens. Furthermore, laboratories and biobanks must comply with strict quality, safety, and documentation standards, which require continuous monitoring, trained personnel, and regular equipment validation. These operational complexities and compliance obligations can slow purchasing decisions and hinder market growth, particularly in developing regions.

Growth Opportunities on the Global Cryopreservation Equipment Market

The growing commercialization of cell and gene therapies is creating significant opportunities for the cryopreservation equipment market. As advanced therapies move toward large-scale manufacturing, demand for high-performance cryogenic freezers, storage systems, and sample preparation equipment continues to increase. In addition, expanding stem cell banking, fertility preservation programs, and biobanking initiatives are driving investments in reliable cryopreservation infrastructure across healthcare and life sciences.

In May 2025, Azenta Life Sciences introduced the CryoPod® Carrier, a portable liquid nitrogen vapor-based cryogenic transport system that maintains temperatures below -150°C for more than three hours while providing integrated temperature monitoring and data logging for secure transport of biological samples. The launch highlights the industry’s increasing focus on strengthening cold-chain integrity and improving the safe handling of temperature-sensitive biological materials.

Key Growth Opportunities:

• Expanding cell and gene therapy manufacturing is creating strong demand for advanced cryogenic storage and sample preservation equipment worldwide.
• Growing investments in biobanking and fertility preservation programs are increasing opportunities for automated and high-capacity cryopreservation systems.
• Rising adoption of smart cryogenic storage technologies with remote monitoring and sample traceability is driving equipment upgrades across laboratories.

Industry Trends Shaping the Global Cryopreservation Equipment Market

The cryopreservation equipment market is witnessing a growing shift toward energy-efficient and high-capacity cryogenic storage systems as laboratories and biobanks seek to reduce operating costs while maximizing sample storage. Manufacturers are increasingly integrating intelligent temperature monitoring, automated inventory management, and predictive maintenance features into cryogenic freezers to improve sample protection, regulatory compliance, and laboratory productivity.

Another key trend is the introduction of compact, space-efficient cryogenic storage equipment tailored to the evolving needs of fertility clinics, biorepositories, and clinical laboratories. In March 2025, Cryoport’s MVE Biological Solutions launched the High-Efficiency (HE) 800 C cryogenic freezer, expanding its next-generation HE Series with a compact, high-capacity storage solution designed to improve workflow efficiency and sample preservation. The product launch reflects the industry’s focus on developing advanced cryogenic equipment that delivers greater storage capacity while optimizing laboratory space and operational performance.

Market Segments Insights:

By Product Type: The Freezers Segment Dominated the Global Cryopreservation Equipment Market

On the basis of product type, the freezers segment accounts for the largest share of the global cryopreservation equipment market owing to their essential role in the long-term preservation of biological samples, including stem cells, embryos, tissues, blood components, and vaccines. They are widely used across biobanks, pharmaceutical and biotechnology companies, hospitals, fertility clinics, and research institutes, where maintaining precise ultra-low temperatures is critical for preserving sample integrity. The expanding adoption of cell and gene therapies and regenerative medicine continues to strengthen demand for advanced cryogenic freezers.

The segment is also benefiting from continuous innovation in energy efficiency, sustainability, and temperature control technologies. Recently, the Thermo Fisher Scientific introduced its next-generation Thermo Scientific™ TSX Universal Series Ultra-Low Temperature (ULT) Freezers, featuring universal V-Drive cooling technology designed to improve energy efficiency, temperature uniformity, and long-term sample protection while reducing laboratories’ environmental footprint. These advancements are encouraging laboratories to replace conventional storage systems with high-performance, sustainable freezer solutions.

By Cryogen Type: The Liquid Nitrogen Sub-category Holds the Largest Share of the Global Cryopreservation Equipment Market

On the basis of cryogen type, the liquid nitrogen segment holds the largest share of the global cryopreservation equipment market due to its exceptional cooling capability and widespread adoption for long-term preservation of biological materials. With a boiling point of approximately -196°C, it provides the ultra-low temperatures required to maintain the viability of stem cells, embryos, tissues, blood components, reproductive cells, and other temperature-sensitive samples. Its extensive use across biobanks, pharmaceutical and biotechnology companies, hospitals, fertility clinics, and research institutes has established it as the preferred cryogen for cryopreservation applications.

The segment’s dominance is further supported by its cost-effectiveness, wide availability, and compatibility with a broad range of cryogenic storage equipment. Compared with other cryogens, liquid nitrogen offers a reliable and efficient solution for maintaining sample integrity over extended storage periods while meeting stringent regulatory and quality requirements. The growing expansion of biobanking, regenerative medicine, cell and gene therapy, and fertility preservation programs continues to drive demand for liquid nitrogen-based cryopreservation systems, reinforcing its leadership in the global market.

Global Cryopreservation Equipment Market Segmentation:

By Product Type:

• Freezers
• Sample Preparation Systems
• Accessories

By Cryogen Type:

• Liquid Nitrogen
• Liquid Helium
• Oxygen
• Argon

By Application:

• Fertility & IVF
• Cell & Gene Therapy
• Biobanking
• Cardiovascular Perfusion
• Others

By End-User:

• Biobanks
• Pharmaceutical & Biotechnology Companies
• Hospitals & Fertility Clinics
• Research Institutes
• Cell Banks
• Others

By Region:

• North America
• Europe
• Asia Pacific
• Latin America
• Middle East & Africa

Regional Analysis: North America Leading the Global Cryopreservation Equipment Market

Geographically, the North America dominates the global cryopreservation equipment market owing to its well-established biotechnology and pharmaceutical industries, advanced healthcare infrastructure, and extensive network of biobanks, research institutes, and fertility clinics. The region continues to witness significant investments in regenerative medicine, cell and gene therapy, stem cell research, and precision medicine, all of which require advanced cryopreservation equipment for the safe storage and preservation of biological samples. The presence of leading equipment manufacturers and strong research funding further strengthens regional market growth.

The region also benefits from the widespread adoption of advanced laboratory technologies, favorable reimbursement and research funding environments, and increasing demand for biobanking and fertility preservation services. Continuous expansion of pharmaceutical research, clinical trials, and advanced therapy manufacturing has accelerated investments in high-performance cryogenic freezers, storage systems, and sample preparation equipment. These factors, along with the growing focus on automation and digital monitoring in laboratory operations, continue to reinforce North America’s leading position in the global market.

Competitive Analysis:

The cryopreservation equipment market is moderately consolidated, with leading companies such as Thermo Fisher Scientific Inc., PHC Holdings Corporation (PHCbi), Eppendorf SE, Azenta Life Sciences, and Cryoport Systems (MVE Biological Solutions) competing through product innovation, technological advancements, and strategic expansion. These companies focus on developing energy-efficient ultra-low temperature freezers, cryogenic storage systems, automated sample management solutions, and advanced monitoring technologies to meet the growing requirements of biobanks, pharmaceutical and biotechnology companies, hospitals, and research institutes.

Competition is further driven by the increasing demand from cell and gene therapy, regenerative medicine, fertility preservation, and biobanking applications. Leading market participants are strengthening their product portfolios through continuous innovation, expanding global distribution networks, and enhancing after-sales service capabilities to improve customer support. Additionally, the integration of automation, digital inventory management, and remote monitoring technologies into cryopreservation equipment is enabling companies to differentiate their offerings while addressing the evolving needs of healthcare and life sciences customers.

Key Companies:

• Thermo Fisher Scientific Inc.
• PHC Holdings Corporation (PHCbi)
• Eppendorf SE
• Azenta Life Sciences
• Cryoport Systems, LLC (MVE Biological Solutions)
• Chart Industries, Inc.
• Haier Biomedical
• Panasonic Healthcare Co., Ltd.
• Air Liquide S.A.
• Worthington Enterprises, Inc. (CryoScience Division)
• VWR International, LLC (Avantor, Inc.)
• Helmer Scientific Inc.

Global Cryopreservation Equipment Market Outlook

• Increasing adoption of cell and gene therapies will continue to drive demand for advanced cryogenic storage and preservation equipment worldwide.
• Growing investments in biobanks, fertility clinics, and regenerative medicine will support the expansion of high-capacity cryopreservation infrastructure.
• Advancements in automation, digital monitoring, and energy-efficient technologies will enhance sample security, operational efficiency, and regulatory compliance.
• Emerging markets in Asia Pacific and Latin America are expected to create new growth opportunities through expanding healthcare infrastructure and life sciences research investments.

Frequently Asked Questions About the Cryopreservation Equipment Market